Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
ID: 335437Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/335437
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement (FOA) aimed at addressing vaccine hesitancy, uptake, and implementation among populations experiencing health disparities. This initiative seeks to promote community-engaged research through a Notice of Special Interest (NOSI) specifically for R01 projects, highlighting the critical need for research in this area. The FOA is expected to be published in December 2020, with applications accepted in February 2021 for fiscal year 2021 funding, and awards anticipated by September 2021. Interested applicants can reach out to Deborah E. Linares, Ph.D., at deborah.linares@nih.gov or by phone at 301-402-2516 for further information.

    Point(s) of Contact
    Integrative Biological and Behavioral Sciences: Deborah E. Linares, Ph.D., M.A.
    (301) 402-2516
    deborah.linares@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and/or ethnic populations. This funding opportunity will solicit research applications that propose novel approaches to tackle these critical health issues, with a focus on fostering meaningful collaborations among applicants. The estimated total program funding for this initiative is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested researchers should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the initiative titled "Transformative Research to Address Health Disparities and Advance Health Equity" (U01 Clinical Trial Optional). This funding opportunity aims to foster innovative research projects that address significant health disparities and promote health equity, encouraging collaborations among researchers. The estimated total program funding is $3 million, with an award ceiling of $500,000 per project, and the application period is expected to open on December 10, 2024, with a closing date of February 28, 2025. Interested applicants should prepare to submit their proposals by the deadline, as the estimated award date is September 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and ethnic populations. This initiative seeks to solicit research applications that propose novel approaches to tackle these critical health issues, thereby promoting equity in health outcomes. The estimated total program funding for this opportunity is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested applicants should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.
    Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Innovation for HIV Vaccine Discovery" (NOFO Number PAR-23-169) aimed at supporting high-risk, high-impact early discovery research focused on innovative vaccine approaches to prevent HIV acquisition and ongoing infection. This initiative emphasizes a Go/No-Go funding approach, requiring applicants to demonstrate measurable progress towards defined goals by the end of Year 2, with continued funding contingent upon meeting these criteria. The overall budget for this initiative is approximately $2 million for fiscal year 2024, with individual project budgets capped at $350,000 per year, and applications must be submitted via Grants.gov by August 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement (FOA) aimed at improving the uptake and use of the dapivirine vaginal ring for HIV prevention. This initiative seeks to advance research on understanding the multilevel facilitators and barriers to the use of the vaginal ring, develop interventions to enhance its uptake and consistent use, and test implementation strategies for optimal delivery. The anticipated funding amount for this grant is up to $500,000, with the FOA expected to be published in Winter 2022 and applications due in Summer 2022. Interested applicants can reach out to Dr. Teri Senn at teri.senn@nih.gov or by phone at 301-761-7852 for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement (FOA) aimed at improving the uptake and use of the dapivirine vaginal ring for HIV prevention. This initiative seeks to advance research on the barriers and facilitators to the use of the vaginal ring, develop supportive interventions, and test implementation strategies for its optimal delivery. The anticipated FOA will utilize the R21 activity code, with an award ceiling of $275,000, and is expected to be published in Winter 2022, with applications due in Summer 2022. Interested applicants can reach out to Dr. Teri Senn at teri.senn@nih.gov or by phone at 301-761-7852 for further information.
    Notice of Intent to Publish a Notice of Funding Opportunity for Social Determinants of Health (SDoH) and Quality of Care Contributors to Cancer Disparities in People with HIV (U01; Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at understanding the impact of social determinants of health (SDoH) on cancer disparities among people with HIV (PWH). This initiative seeks applications for research that explores health disparities throughout the cancer care continuum, including aspects such as screening, diagnosis, treatment, quality of life, and survivorship, with the goal of enhancing the NIH's research portfolio in this critical area. The funding opportunity, which will utilize the U01 cooperative agreement mechanism, anticipates awarding approximately four grants with a ceiling of $500,000 each, contributing to an estimated total program funding of $3 million. Interested applicants should prepare for the expected publication of the NOFO in fall 2024, with application deadlines projected for winter 2025, 2026, and 2027, and an anticipated award date of July 1, 2025.
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that addresses barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages studies that promote equitable dissemination among underrepresented communities and explore the de-implementation of ineffective practices, emphasizing the importance of interdisciplinary collaboration and stakeholder engagement. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and government organizations, with funding amounts determined by NIH appropriations and the quality of applications. The application deadline is May 7, 2025, and interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at researching the intersection of cancer stigma and HIV stigma in individuals diagnosed with both conditions. This initiative seeks to advance understanding of how these stigmas affect cancer outcomes among HIV-positive individuals, promote stigma reduction interventions, and encourage research in areas with high HIV-cancer burdens. The NIH plans to award up to six R01 grants, each with a ceiling of $500,000, as part of a total estimated funding pool of $5 million, with the NOFO expected to be published in late Summer 2024 and applications due in late Fall 2024. Interested applicants are encouraged to prepare by reviewing related presentations and materials available online.
    Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for "Dissemination and Implementation Research in Health" (R03), aimed at supporting studies that identify and address barriers to the adoption and integration of evidence-based health interventions, particularly among underrepresented communities. This initiative emphasizes the importance of both dissemination research, which focuses on distributing health information, and implementation research, which examines the practical deployment of strategies. Eligible organizations can apply for grants of up to $50,000 for a project period of up to two years, with a requirement to submit a "Plan for Enhancing Diverse Perspectives" to promote inclusivity in research efforts. The application deadline is January 16, 2025, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html.